Average purchase costs of 3GCs and all oral antimicrobials per 100 patient-days from Phases 1–4. حسب Naoya Itoh (6029276)

الموضوعات:

Estimated number of incidences and medical costs in 10 Years after 2021. حسب Ayako Shoji (78037)

الموضوعات:

Change in health utilization measures by group and difference in magnitude of change between groups. حسب Emily Lyles (3174990)

الموضوعات:

The trend of patient characteristics, risk factors, and risk scores. حسب Ayako Shoji (78037)

الموضوعات:

Factors related to risk scores. حسب Ayako Shoji (78037)

الموضوعات:

Fig 4 - حسب Ayako Shoji (78037)

الموضوعات:

The trend of risk scores. حسب Ayako Shoji (78037)

الموضوعات:

Fig 3 - حسب Ayako Shoji (78037)

الموضوعات:

Fig 1 - حسب Ayako Shoji (78037)

الموضوعات:

Change in health care-seeking and medicines for household member illness. حسب Emily Lyles (3174990)

الموضوعات:

Relative percent change in billing frequency for medical use (2019 vs 2020). حسب Jinah Sim (15140709)

الموضوعات:

Relative percent change (%) in cancer incidence by cancer type (2019 vs 2020). حسب Jinah Sim (15140709)

الموضوعات:

Relative percent change in billing charges related to medical use (2019 vs 2020). حسب Jinah Sim (15140709)

الموضوعات:

Transportation plan when the amount of medical waste generated increases significantly. حسب Chen Hao (352436)

This is Transportation plan when the amount of medical waste generated increases significantly. حسب Chen Hao (352436)

Change in log health expenditures for most recent care and in the preceding month^a. حسب Emily Lyles (3174990)

الموضوعات:

Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of extended-spectrum β-lactamase (ESBL)- producing Enterobacteriaceae per 1000 patients, by month, during the pre-intervention period (Phase 1) and interven... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the incidence of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) per 1000 patients, by month, during the pre-intervention period (Phase 1) and interventional pe... حسب Naoya Itoh (6029276)

الموضوعات:

Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. حسب Naoya Itoh (6029276)

الموضوعات: